Joseph Kuo

613 total citations
27 papers, 494 citations indexed

About

Joseph Kuo is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Joseph Kuo has authored 27 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Microbiology. Recurrent topics in Joseph Kuo's work include Bacterial Infections and Vaccines (7 papers), Pneumonia and Respiratory Infections (6 papers) and Vector-borne infectious diseases (5 papers). Joseph Kuo is often cited by papers focused on Bacterial Infections and Vaccines (7 papers), Pneumonia and Respiratory Infections (6 papers) and Vector-borne infectious diseases (5 papers). Joseph Kuo collaborates with scholars based in United States, Switzerland and Sweden. Joseph Kuo's co-authors include Philippe Gallay, John L. Coulehan, Richard H. Michaels, Thomas K. Welty, Ronald F. Schell, Ruth A. Schwalbe, Thomas F. Warner, Dean T. Nardelli, Anne Lindberg and Michael G. Douglas and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Joseph Kuo

26 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Kuo United States 13 265 199 100 94 81 27 494
James O'Brien United States 11 251 0.9× 42 0.2× 34 0.3× 54 0.6× 141 1.7× 18 464
Frank Kowalzik Germany 9 237 0.9× 154 0.8× 99 1.0× 163 1.7× 61 0.8× 22 492
Timothy J. Holzer United States 12 366 1.4× 55 0.3× 140 1.4× 235 2.5× 251 3.1× 23 716
Kim S. Erlich United States 12 595 2.2× 76 0.4× 34 0.3× 128 1.4× 151 1.9× 16 752
Michèle Aymard France 13 377 1.4× 59 0.3× 34 0.3× 128 1.4× 65 0.8× 27 494
J Slusarczyk Poland 14 444 1.7× 111 0.6× 38 0.4× 90 1.0× 45 0.6× 71 622
Edward R. Leake United States 7 242 0.9× 274 1.4× 94 0.9× 46 0.5× 63 0.8× 8 428
Dennis O. Gor United States 10 129 0.5× 52 0.3× 65 0.7× 66 0.7× 194 2.4× 12 434
P. H. Makela Finland 11 531 2.0× 436 2.2× 56 0.6× 58 0.6× 84 1.0× 13 781
L C Bartos United States 10 304 1.1× 341 1.7× 98 1.0× 69 0.7× 31 0.4× 10 543

Countries citing papers authored by Joseph Kuo

Since Specialization
Citations

This map shows the geographic impact of Joseph Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Kuo more than expected).

Fields of papers citing papers by Joseph Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Kuo. The network helps show where Joseph Kuo may publish in the future.

Co-authorship network of co-authors of Joseph Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Kuo. A scholar is included among the top collaborators of Joseph Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Kuo. Joseph Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunawardana, Manjula, Simon G. Webster, Paul Webster, et al.. (2022). Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis. Scientific Reports. 12(1). 8224–8224. 11 indexed citations
2.
Gunawardana, Manjula, Rob Fanter, Simon G. Webster, et al.. (2022). Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis. Pharmaceutical Research. 40(7). 1657–1672. 3 indexed citations
3.
Gunawardana, Manjula, Simon G. Webster, Patricia Galván, et al.. (2020). Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis. Frontiers in Pharmacology. 11. 569373–569373. 19 indexed citations
4.
Bobardt, Michael, Joseph Kuo, Udayan Chatterji, et al.. (2020). The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice. PLoS ONE. 15(1). e0227715–e0227715. 1 indexed citations
5.
Bobardt, Michael, Joseph Kuo, Udayan Chatterji, et al.. (2019). The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate. PLoS ONE. 14(2). e0211746–e0211746. 29 indexed citations
6.
Kuo, Joseph, Michael Bobardt, Udayan Chatterji, et al.. (2019). A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models. Journal of Pharmacology and Experimental Therapeutics. 371(2). 231–241. 41 indexed citations
7.
Kuo, Joseph, et al.. (2019). Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis. Frontiers in Pharmacology. 10. 1129–1129. 16 indexed citations
8.
Grönberg, Alvar, Lisa Longato, Krista Rombouts, et al.. (2019). Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis. Cells. 8(11). 1409–1409. 18 indexed citations
10.
Kuo, Joseph, Thomas F. Warner, & Ronald F. Schell. (2017). Borrelia-primed and -infected mice deficient of interleukin-17 develop arthritis after neutralization of gamma-interferon. Pathogens and Disease. 75(2). 2 indexed citations
11.
Kuo, Chung‐Feng Jeffrey, et al.. (2017). Prognostic value of tumor volume for patients with advanced lung cancer treated with chemotherapy. Computer Methods and Programs in Biomedicine. 144. 165–177. 8 indexed citations
12.
Kuo, Joseph, Thomas F. Warner, Erik Munson, Dean T. Nardelli, & Ronald F. Schell. (2016). Arthritis is developed inBorrelia-primed and -infected mice deficient of interleukin-17. Pathogens and Disease. 74(7). ftw077–ftw077. 5 indexed citations
13.
Kuo, Joseph, et al.. (2013). Interleukin-10 (IL-10) Inhibits Borrelia burgdorferi-Induced IL-17 Production and Attenuates IL-17-Mediated Lyme Arthritis. Infection and Immunity. 81(12). 4421–4430. 17 indexed citations
14.
Kuo, Joseph, Dean T. Nardelli, Thomas F. Warner, Steven M. Callister, & Ronald F. Schell. (2011). Interleukin-35 Enhances Lyme Arthritis inBorrelia-Vaccinated and -Infected Mice. Clinical and Vaccine Immunology. 18(7). 1125–1132. 37 indexed citations
15.
Glodé, Mary P., et al.. (1988). Reimmunization of children immunized at 18 months of age with Haemophilus influenzae type b vaccine. The Journal of Pediatrics. 112(5). 703–708. 1 indexed citations
17.
Kuo, Joseph, et al.. (1985). Evidence for covalent attachment of phospholipid to the capsular polysaccharide of Haemophilus influenzae type b. Journal of Bacteriology. 163(2). 769–773. 39 indexed citations
19.
Coulehan, John L., et al.. (1984). Epidemiology of Haemophilus influenzae type B disease among Navajo Indians.. PubMed. 99(4). 404–9. 75 indexed citations
20.
Liu, Irwin, et al.. (1982). Duration of maternally derived immunity to tetanus and response in newborn foals given tetanus antitoxin. American Journal of Veterinary Research. 43(11). 2019–2022. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026